MediBeacon Inc. today announced the U.S. Food and Drug Administration (FDA) has approved the MediBeacon® TGFR for the assessment of kidney function in patients with normal or impaired renal function.
He has sporadic non-specific skin lesions. He has a high titer of ... patient education, and nursing measures. Using the format here, you are invited to submit your "Clinical Snapshot" to ...